the reversal of lymphopenia and treatment of multiply relapsed locally advanced or metastatic pancreatic cancer Over 100 participants have now received ANKTIVA in cancer prevention trial with goal to ...

They are acting on it, deploying AI agents to empower teams, drive growth, and deliver measurable impact. Combined with no-code innovation, this shift is setting the stage for the next era of ...

The contract closed at 127.62. The market closing above the 9 day MA (123.40) is confirmation that the trend momentum is bullish. A close below the 9 MA would negate the weekly bullish short-term ...

As China moves to complete the creation of military outposts in the South China Sea, Beijing’s negotiation with southeastern Asian nations over a binding code of conduct is gaining momentum. But U.S.

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced certain operational results following approval of the permanent J-code (J9028) ...